Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Randeep S. Sangha"'
Autor:
Winson Y. Cheung, Chantelle Carbonell, Vishal Navani, Randeep S. Sangha, Emmanuel M. Ewara, Julia Elia-Pacitti, Sandra Iczkovitz, Tamer N. Jarada, Matthew T. Warkentin
Publikováno v:
Current Oncology, Vol 31, Iss 8, Pp 4382-4396 (2024)
There is limited information on the treatment trajectory and outcomes of patients with advanced cEGFRm NSCLC treated with osimertinib in routine clinical practice in Canada. By using and analyzing population-based administrative data and detailed cha
Externí odkaz:
https://doaj.org/article/968bf2ed25324428abf61531d74ebe18
Autor:
Christian K. Kollmannsberger, Fernando Doñate, Karen Morrison, Banmeet Anand, Fabio Trave, Aya Wiseman, Leonard Reyno, Stella K. Kim, Roberto Pili, D. Scott Ernst, Randeep S. Sangha, Bruce G. Redman, Elisabeth I. Heath, Toni K. Choueiri, Ana M. Molina, Robert J. Motzer, John A. Thompson
Supplementary Figure Legend
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52d5507d43b98b6cb1acf9a1e2e3158c
https://doi.org/10.1158/1078-0432.22470848
https://doi.org/10.1158/1078-0432.22470848
Autor:
Christian K. Kollmannsberger, Fernando Doñate, Karen Morrison, Banmeet Anand, Fabio Trave, Aya Wiseman, Leonard Reyno, Stella K. Kim, Roberto Pili, D. Scott Ernst, Randeep S. Sangha, Bruce G. Redman, Elisabeth I. Heath, Toni K. Choueiri, Ana M. Molina, Robert J. Motzer, John A. Thompson
Supplementary Figure 6. Serum concentration time profiles for AGS-16C3F(CHO) Total Antibody (TAb) (data is presented as Mean {plus minus} SD)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::198c16e53abafaa965133d338dad8dc2
https://doi.org/10.1158/1078-0432.22470851.v1
https://doi.org/10.1158/1078-0432.22470851.v1
Autor:
Christian K. Kollmannsberger, Fernando Doñate, Karen Morrison, Banmeet Anand, Fabio Trave, Aya Wiseman, Leonard Reyno, Stella K. Kim, Roberto Pili, D. Scott Ernst, Randeep S. Sangha, Bruce G. Redman, Elisabeth I. Heath, Toni K. Choueiri, Ana M. Molina, Robert J. Motzer, John A. Thompson
Supplementary Figure 2. Serum concentration time profiles for AGS-16C3F(CHO) antibody drug conjugate (ADC) (data is presented as Mean {plus minus} SD)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b0d3847c6c92a4dbe181a1f08332e72
https://doi.org/10.1158/1078-0432.22470863
https://doi.org/10.1158/1078-0432.22470863
Autor:
Antonio Calles, Philip Komarnitsky, Lei He, Elizabeth Hoening, Silpa Nuthalapati, Tian Tian, Beibei Hu, Nashat Y. Gabrail, D. Ross Camidge, Young Kwang Chae, Santiago Viteri, Randeep S. Sangha, Martijn P. Lolkema, Elena Garralda, Lauren A. Byers, Harry J.M. Groen, Florence Atrafi
Purpose:This study examined safety, pharmacokinetics, and efficacy of veliparib, a PARP inhibitor, combined with carboplatin and etoposide in patients with extensive-stage (ED) small cell lung cancer (SCLC) and other solid tumors.Patients and Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45f8bb756200cc683bad575e64c78e34
https://doi.org/10.1158/1078-0432.c.6529248
https://doi.org/10.1158/1078-0432.c.6529248
Autor:
Christian K. Kollmannsberger, Fernando Doñate, Karen Morrison, Banmeet Anand, Fabio Trave, Aya Wiseman, Leonard Reyno, Stella K. Kim, Roberto Pili, D. Scott Ernst, Randeep S. Sangha, Bruce G. Redman, Elisabeth I. Heath, Toni K. Choueiri, Ana M. Molina, Robert J. Motzer, John A. Thompson
Purpose: To determine the safety, pharmacokinetics, and recommended phase II dose of an antibody–drug conjugate (ADC) targeting ectonucleotide phosphodiesterases-pyrophosphatase 3 (ENPP3) conjugated to monomethyl auristatin F (MMAF) in subjects wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c94124b1516adede1ca87dc90fc76c4
https://doi.org/10.1158/1078-0432.c.6527702
https://doi.org/10.1158/1078-0432.c.6527702
Autor:
Antonio Calles, Philip Komarnitsky, Lei He, Elizabeth Hoening, Silpa Nuthalapati, Tian Tian, Beibei Hu, Nashat Y. Gabrail, D. Ross Camidge, Young Kwang Chae, Santiago Viteri, Randeep S. Sangha, Martijn P. Lolkema, Elena Garralda, Lauren A. Byers, Harry J.M. Groen, Florence Atrafi
Table S1. Tolerability of veliparib, carboplatin, and etoposide over entire combination cycles treatment period Table S2. Mean {plus minus} SD (% CV) pharmacokinetic parameters of veliparib following oral administration of veliparib in combination wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62ecc6c737b415ca25041ac695f5e522
https://doi.org/10.1158/1078-0432.22475985.v1
https://doi.org/10.1158/1078-0432.22475985.v1
Autor:
Christian K. Kollmannsberger, Fernando Doñate, Karen Morrison, Banmeet Anand, Fabio Trave, Aya Wiseman, Leonard Reyno, Stella K. Kim, Roberto Pili, D. Scott Ernst, Randeep S. Sangha, Bruce G. Redman, Elisabeth I. Heath, Toni K. Choueiri, Ana M. Molina, Robert J. Motzer, John A. Thompson
Supplementary Figure 4. Serum concentration time profiles for AGS-16C3F(CHO) free cys-mcMMAF (data is presented as Mean {plus minus} SD)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd79503afe00127ece2c04b6f36e73bf
https://doi.org/10.1158/1078-0432.22470857
https://doi.org/10.1158/1078-0432.22470857
Autor:
Christian K. Kollmannsberger, Fernando Doñate, Karen Morrison, Banmeet Anand, Fabio Trave, Aya Wiseman, Leonard Reyno, Stella K. Kim, Roberto Pili, D. Scott Ernst, Randeep S. Sangha, Bruce G. Redman, Elisabeth I. Heath, Toni K. Choueiri, Ana M. Molina, Robert J. Motzer, John A. Thompson
Supplementary Figure 3. Serum concentration time profiles for AGS-16M8F(Hyb) free cys-mcMMAF (data is presented as Mean {plus minus} SD)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea02bf65e45915d69700ae0a57f914cc
https://doi.org/10.1158/1078-0432.22470860
https://doi.org/10.1158/1078-0432.22470860
Autor:
Christian K. Kollmannsberger, Fernando Doñate, Karen Morrison, Banmeet Anand, Fabio Trave, Aya Wiseman, Leonard Reyno, Stella K. Kim, Roberto Pili, D. Scott Ernst, Randeep S. Sangha, Bruce G. Redman, Elisabeth I. Heath, Toni K. Choueiri, Ana M. Molina, Robert J. Motzer, John A. Thompson
Supplementary Figure 5. Serum concentration time profiles for AGS-16M8F(Hyb) Total Antibody (TAb) (data is presented as Mean {plus minus} SD)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5f443fa478a7628e9bb51fafe1485ff
https://doi.org/10.1158/1078-0432.22470854.v1
https://doi.org/10.1158/1078-0432.22470854.v1